In vitro expression of genetically encoded non-standard peptides consisting of exotic amino acid building blocks.
Ribosomal incorporation of non-proteinogenic amino acids (NPaa) into peptides have made significant progress in recent years. These non-standard peptides have been utilized for a plethora of applications in the fields of chemical biology and therapeutics. Here we comprehensively review recent advances for the incorporation of exotic NPaa into peptide chain using custom-made in vitro translation system under reprogrammed genetic code. Such approaches allow us to express non-standard peptides containing various amino acid building blocks in the mRNA-encoding manner, leading to the discovery of therapeutically useful macrocyclic molecules with molecular weight of less than 2500 Da.